These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34021647)

  • 21. RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis.
    Cho H; Herzka T; Zheng W; Qi J; Wilkinson JE; Bradner JE; Robinson BD; Castillo-Martin M; Cordon-Cardo C; Trotman LC
    Cancer Discov; 2014 Mar; 4(3):318-33. PubMed ID: 24444712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts.
    Comito G; Pons Segura C; Taddei ML; Lanciotti M; Serni S; Morandi A; Chiarugi P; Giannoni E
    Oncotarget; 2017 Jan; 8(1):118-132. PubMed ID: 27223431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice.
    Saif JM; Vadakekolathu J; Rane SS; McDonald D; Ahmad M; Mathieu M; Pockley AG; Durrant L; Metheringham R; Rees RC; McArdle SE
    Eur J Immunol; 2014 Apr; 44(4):994-1004. PubMed ID: 24338683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.
    Butt NA; Kumar A; Dhar S; Rimando AM; Akhtar I; Hancock JC; Lage JM; Pound CR; Lewin JR; Gomez CR; Levenson AS
    Cancer Med; 2017 Nov; 6(11):2673-2685. PubMed ID: 29024573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.
    Manda KR; Tripathi P; Hsi AC; Ning J; Ruzinova MB; Liapis H; Bailey M; Zhang H; Maher CA; Humphrey PA; Andriole GL; Ding L; You Z; Chen F
    Oncogene; 2016 Jun; 35(25):3282-92. PubMed ID: 26477312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BHLHE22 drives the immunosuppressive bone tumor microenvironment and associated bone metastasis in prostate cancer.
    Yin C; Wang M; Wang Y; Lin Q; Lin K; Du H; Lang C; Dai Y; Peng X
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36941015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The absence or overexpression of IL-15 drastically alters breast cancer metastasis via effects on NK cells, CD4 T cells, and macrophages.
    Gillgrass A; Gill N; Babian A; Ashkar AA
    J Immunol; 2014 Dec; 193(12):6184-91. PubMed ID: 25355926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of OGR1 in myeloid-derived cells in prostate cancer.
    Yan L; Singh LS; Zhang L; Xu Y
    Oncogene; 2014 Jan; 33(2):157-64. PubMed ID: 23222714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
    Chen Z; Trotman LC; Shaffer D; Lin HK; Dotan ZA; Niki M; Koutcher JA; Scher HI; Ludwig T; Gerald W; Cordon-Cardo C; Pandolfi PP
    Nature; 2005 Aug; 436(7051):725-30. PubMed ID: 16079851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting ALCAM in the cryo-treated tumour microenvironment successfully induces systemic anti-tumour immunity.
    Kudo-Saito C; Fuwa T; Kawakami Y
    Eur J Cancer; 2016 Jul; 62():54-61. PubMed ID: 27208904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
    Lu W; Liu S; Li B; Xie Y; Izban MG; Ballard BR; Sathyanarayana SA; Adunyah SE; Matusik RJ; Chen Z
    Oncogene; 2017 Mar; 36(10):1364-1373. PubMed ID: 27869166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis.
    Höppener DJ; Nierop PMH; Hof J; Sideras K; Zhou G; Visser L; Gouw ASH; de Jong KP; Sprengers D; Kwekkeboom J; Vermeulen PB; Grünhagen DJ; Verhoef C
    Br J Cancer; 2020 Jul; 123(2):196-206. PubMed ID: 32418992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of targeted AKT inhibition in genetically engineered mouse models of PTEN-deficient prostate cancer.
    De Velasco MA; Kura Y; Yoshikawa K; Nishio K; Davies BR; Uemura H
    Oncotarget; 2016 Mar; 7(13):15959-76. PubMed ID: 26910118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of prostate inflammation on lesion development in the POET3(+)Pten(+/-) mouse model of prostate carcinogenesis.
    Burcham GN; Cresswell GM; Snyder PW; Chen L; Liu X; Crist SA; Henry MD; Ratliff TL
    Am J Pathol; 2014 Dec; 184(12):3176-91. PubMed ID: 25455686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer.
    Wu AC; He Y; Broomfield A; Paatan NJ; Harrington BS; Tseng HW; Beaven EA; Kiernan DM; Swindle P; Clubb AB; Levesque JP; Winkler IG; Ling MT; Srinivasan B; Hooper JD; Pettit AR
    J Pathol; 2016 Jun; 239(2):218-30. PubMed ID: 27174786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased T-cell Infiltration Elicited by
    Loveridge CJ; Mui EJ; Patel R; Tan EH; Ahmad I; Welsh M; Galbraith J; Hedley A; Nixon C; Blyth K; Sansom O; Leung HY
    Cancer Res; 2017 Jun; 77(12):3158-3168. PubMed ID: 28515147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer.
    Adissu HA; McKerlie C; Di Grappa M; Waterhouse P; Xu Q; Fang H; Khokha R; Wood GA
    Prostate; 2015 Dec; 75(16):1831-43. PubMed ID: 26332574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
    Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
    Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer.
    Griesmann H; Drexel C; Milosevic N; Sipos B; Rosendahl J; Gress TM; Michl P
    Gut; 2017 Jul; 66(7):1278-1285. PubMed ID: 27013602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Obesity on the Regulation of Macrophage Population in the Prostate Tumor Microenvironment.
    Galván GC; Johnson CB; Price RS; Liss MA; Jolly CA; deGraffenried LA
    Nutr Cancer; 2017 Oct; 69(7):996-1002. PubMed ID: 28945110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.